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Abstract
The electrochemical behavior of the antileukemia drug glivec was investigated at a glassy carbon electrode (GCE).
The oxidation is a complex, pH-dependent, irreversible electrode process involving the transfer of 2 electrons and 2
protons and the formation of an electroactive product, Pglivec, which strongly adsorbs on the GCE surface and
undergoes reversible oxidation. The adsorption of Pglivec at the GCE surface yields a compact monolayer that inhibits
further oxidation of glivec. The electrochemical reduction is a simple pH dependent irreversible process involving the
transfer of 2 electrons and 2 protons and occurs with the formation of a nonelectroactive product. The diffusion
coefficient of glivec was calculated to be DO¼ 7.35 106 cm2 s1 in pH 4.5 0.1 M acetate buffer.
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1. Introduction
Protein kinases form a major class of enzymes that play an
important role in signal transduction pathways, regulating a
number of cellular functions such as cell growth, differ-
entiation and cell death [1]. For this reason, protein tyrosine
kinases became attractive targets in the research for
therapeutic agents, not only against cancer but also against
manyother diseases [1 – 3]. In recent years, different types of
tyrosine kinase inhibitors have been described and reviewed
[4]. Althoughmost of these drugs served as tools to set up in
vivo assay systems and to prove their functionality, only a
few demonstrated in vivo efficacy.
Glivec (Gleevec, STI 571, or imatinib mesylate) [5],
Scheme 1, one of the most potent in vitro and in vivo
inhibitor of ABL-kinase, the center to the pathogenesis of
chronic myelogenous leukemia (CML), is a recently devel-
oped drug that belongs to the 2-phenylaminopyrimidine
class [5, 6]. Glivec acts specifically by blocking the binding
site for ATP in the ABL-kinase [7]. This inhibits the ability
of ABL to transfer phosphate groups from ATP and
phosphorylate tyrosine residues on substrate proteins,
which in turn prevents the transduction of energy signals
necessary for ABL-induced cellular proliferation and
apoptosis [8]. Based on its activity on CML, glivec is
undergoing extensive investigation for its activity against
other tumor types [9, 10].
As already mentioned, glivec has been screened to target
tyrosine kinases but, recently, using an alkaline comet assay
itwas shown that glivec also inducesDNAdamage in human
leukemic cells expressing the BCR-ABL protein [11]. In
these studies, glivecdidnot induceDNAstrandbreaks in the
direct interaction with DNA but rather alkali-labile sites.
Moreover, the pretreatment of the BCR-ABL protein
expressing cells with vitamins A, C and E reduced the
extent of DNA damage caused by glivec. However, as a
main result, the mechanism of the antileukemic action of
glivecmay involve not only the inhibition ofBCR-ABL, but
alsoDNAdamage in the cells expressing this fusion protein.
Although glivec has proven to be a highly promising
treatment for CML, the patients showing significant hema-
tological and cytogenetical responses, resistance to glivec is
still a problem mainly in patients in the accelerated or blast
crisis phases of the disease [12, 13].Whereas responses have
been durable in patients in the chronic phase, blast crisis
patients quite oftenundergo relapse.Also, it has been shown
that specific mutations within the kinase domain are a
primary cause of glivec resistance. The main way to over-
come this is a combination therapy with other drugs [14].Scheme 1. Glivec chemical structure.
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Being a relatively new drug, there are only a few
references about glivec reactions mechanism in the speci-
alized literature. Most deal with the analytical detection of
glivec and its mainmetabolite in urine or human plasma and
are based on liquid chromatography tandem mass spec-
trometry [15 – 19], capillary zone electrophoresis [20] and
more recently on voltammetric methods [21].
Due to their high sensitivity, voltammetric methods have
been successfully used for the detection and determination
of various biological compounds [22 – 25]. Besides the
analytical goals, investigations of the redox behavior of
different compounds by means of electrochemical techni-
ques have the potential for providing valuable insights into
the redox reactions of these molecules.
Therefore, the present study is concerned with the
investigation of the electron transfer properties of glivec
using cyclic, differential pulse and square-wave voltamme-
try and a glassy carbon electrode. The investigation of the
electrochemical oxidation and reduction mechanisms of
glivec is important since this could result in a better
understanding of the data already known [21] and increase
the overall knowledge of glivecMs physiological mechanisms
of action.
2. Experimental
2.1. Materials and Reagents
Glivec capsules of 100 mg obtained from Novartis (Portu-
gal), were used without further purification. Stock solutions
of 100 mM were prepared in purified water and stored at
4 8C. Solutions of different concentrations of glivec were
prepared by dilution of the appropriate quantity in support-
ing electrolyte.
All supporting electrolyte solutions, Table 1, were pre-
pared using analytical grade reagents and purified water
from a Millipore Milli-Q system (conductivity 0.1 mS
cm1).
Microvolumes were measured using EP-10 and EP-100
PlusMotorizedMicroliter Pippettes (Rainin InstrumentCo.
Inc., Woburn, USA). The pH measurements were carried
out with a Crison micropH 2001 pH-meter with an Ingold
combined glass electrode. All experiments were done at
room temperature (25 1 8C).
2.2. Voltammetric Parameters and Electrochemical Cells
Voltammetric experiments were carried out using a mAuto-
lab running with GPES 4.9 software, Eco-Chemie, Utrecht,
The Netherlands. The experimental conditions for differ-
ential pulse voltammetry (DPV) were: pulse amplitude
50 mV, pulsewidth 70ms, scan rate 5 mV s1.Measurements
were carriedout using a glassy carbonelectrode (GCE) (d¼
1.5 mm), with a Pt wire counter electrode, and a Ag/AgCl
(3 MKCl) electrode as reference, in a 0.5 mL one-compart-
ment electrochemical cell.
TheGCEwas polished using diamond spray (particle size
1 mm) before every electrochemical assay. After polishing,
the electrode was rinsed thoroughly with Milli-Q water for
30 s; then it was sonicated for 1 minute in an ultrasound bath
and again rinsed with water. After this mechanical treat-
ment, the GCE was placed in buffer electrolyte and various
DP voltammograms were recorded until a steady state
baseline voltammogram was obtained. This procedure
ensured very reproducible experimental results.
2.3. Acquisition and Presentation of Voltammetric Data
All the voltammograms presented were background-sub-
tracted and baseline-corrected using the moving average
application with a step window of 5 mV included in GPES
version 4.9 software. Thismathematical treatment improves
the visualization and identification of peaks over the
baseline without introducing any artifact, although the
peak intensity is in some cases reduced (<10%) relative to
that of the untreated curve. Nevertheless, this mathematical
treatment of the original voltammograms was used in the
presentation of all experimental voltammograms for a
better and clearer identification of the peaks. The values
for peak current presented in all plotswere determined from
the original untreated voltammograms after subtraction of
the base line.
3. Results and Discussion
Initial studies concerning the voltammetric behavior of
glivec at a GCE were carried out in pH 4.5 0.1 M acetate
buffer. The cyclic voltammograms, Figure 1, were obtained
in a solution of 50 mM glivec saturated with N2. During the
voltammetric measurement a constant flux of N2 was kept
over the solution surface in order to avoid the diffusion of
atmospheric oxygen into the solution of glivec.
Several peaks can be observed in Figure 1. The reduction
and oxidation of glivec occur independently of each other
and were investigated separately.
Table 1. Supporting electrolytes, 0.1 M ionic strength.
pH Composition
2.6 HClþKCl
3.8 HAcOþNaAcO
4.5 HAcOþNaAcO
5.5 HAcOþNaAcO
6.2 NaH2PO4þNa2HPO4
7 NaH2PO4þNa2HPO4
8.2 NaH2PO4þNa2HPO4
9.1 NaOHþNa2B2O7
12 NaOHþKCl
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3.1. Oxidation
3.1.1. Cyclic Voltammetry
The oxidation of glivec at a GCE was first studied in pH 4.5
0.1 M acetate buffer. The CV obtained in a 50 mM glivec
solution at a scan rate of v¼ 100 mV s1, Figure 2A, shows
two anodic peaks at E1pa¼þ1.00 V, peak 1a and at E2pa¼
þ1.25 V, peak 2a.On the negative-going scan, two reduction
peaks occurred at E2pc¼þ0.96 V, peak 2c and at E3pc¼
þ0.28 V, peak 3c respectively. These cathodic peaks corre-
spond to the reduction of the glivec oxidation products
formed at theGCEsurface.A subsequentCVscan showeda
new oxidation peak 3a atE3pa¼þ0.34 V. At the same time, a
decrease of peaks 1a and 2a was also observed due to the
adsorption of glivec and/or its oxidation product on the
GCE surface.
In a new experiment, using a clean GCE, the scan
directionwas inverted immediately after peak 1a and before
peak 2a. On the negative going scan, only peak 3c appeared
at E3pc¼þ0.28 V, Figure 2B. Thus, peak 3c corresponds to
the reduction of the species formed at theGCE surface after
Fig. 1. CV obtained with a GCE in a solution of 50 mM glivec in
pH 4.5 0.1 M acetate buffer saturated with N2; (—) 1
st and ( · · · · · · )
2nd scan at v¼ 500 mV s1.
Fig. 2. CVs obtained with a GCE in a solution of: A) 50 mM glivec, (—) 1st and ( · · · · · · ) 2nd scan at v¼ 0.10 V s1; B) 10 mM glivec, (—) 1st
and ( · · · · · · ) 2nd scan at v¼ 0.10 V s1, C) 1st scan at (– – ––) 0.40, ( · · · · · · ) 0.75, and (—) 1.50 V s1, D) (—) 1st and ( · · · · · · ) 2nd scan at v¼
1.00 V s1 in pH 4.3 0.1 M acetate buffer.
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glivec oxidation at E1pa¼þ1.00 V, peak 1a. This glivec
oxidation product will be designated as Pglivec. Moreover,
peak 3a occurs on a subsequent CV scan at E3pa¼þ0.34 V,
the E3paE3pc¼ 0.06 V denoting a reversible couple corre-
sponding to adsorbed Pglivec reaction. The big decrease of
peak 1a is due to the strong adsorption of Pglivec at the GCE
surface, that reduces the available electrode surface area.
Also, in the above described experiment, peak 2c does not
occur, Figure 2B, showing that this peak corresponds to the
species oxidized at Epa
2¼þ1.25 V.
CVs were obtained for different scan rates in a solution of
10 mM glivec in pH 4.5 0.1 M acetate buffer always using a
clean GCE surface. Peak 1a becomes broader on increasing
the scan rate, and for v> 200 mV s1 two peaks occur,
Figure 2C. The first narrow high peak 1 ’a appears at a lower
potential followed by a smaller and broader peak 1 ’’a.
The above result can be explained taking into account the
hindering of the oxidation reaction of glivec as a conse-
quence of electrode surface blockage due to the adsorption
of the glivec oxidation product, peak 3a, Pglivec [26]. Glivec
molecules in close proximity to the electrode surface are
oxidized giving rise to peak 1 ’a and to Pglivec that remains
adsorbed on the GCE surface forming a noncompact
monolayer. Further oxidation of glivec molecules diffusing
from the bulk solution towards the electrode, peak 1 ’’a, is
more difficult because it occurs through the layer of
adsorbed Pglivec. However, after the process corresponding
to peak 1 ’’a the layer of Pglivec becomes more compact
covering the electrode surface and impeding further oxida-
tionof glivecmolecules that diffuse from the solution.This is
also confirmed by the considerable decrease of peak 1 ’a and
disappearance of peak 1 ’’a observed on the second scan,
Figure 2D.
The reduction peak 3c always appeared on the negative-
going scans and the current increases with increasing scan
rate, Figure 2C. Also, the anodic peak 3a was always
obtained by recording consecutive voltammograms in the
same solution, forming a reversible couple with peak 3c,
Figure 2D. At the same time, peaks 1 ’a and 1 ’’a were
considerably diminished.
The effect of the scan rate on the current and potential of
peak 1awas also investigated (not shown).Cyclic voltammo-
gramswere sequentially recorded for 5 v 2000 mV s1 in
pH 4.5 0.1 M acetate buffer containing 10 mM glivec always
using a freshly polished electrode surface.
A linear dependence of peak current 1a with square root
of scan rate (v1/2) was observed for 5 v 200 mV s1. For
higher scan rates, deviation from linearity was obtained due
to the adsorption of Pglivec at the GCE surface [27].
The peak 1a potential varies linearly with the logarithm of
the scan rate changing by 31 mV per decade for 5 v
200 mV s1, showing that the glivec oxidation reaction is
diffusion-controlled. For higher scan rates, peak 1a became
more positive with increasing scan rate and the slope of the
linear variation changed to 71 mV per decade. This change
of the slope indicates that the reaction passes gradually from
a diffusion-controlled process to a surface reaction on
increasing the scan rate [27].
3.1.2. Differential Pulse Voltammetry
The electrochemical oxidation of glivec was studied over a
wide pH range between 2 and 13 using DPV. The DP
voltammograms, Figure 3A, were all recorded in solutions
of 5 mM glivec in different electrolytes of 0.1 M ionic
strength.
In very acidicmedia (pH< 2), nooxidationpeak for glivec
was observed andonly at pH 2.6 and 9.2 bothpeaks 1 ’a and 1 ’’a
were seen, Figure 3A.
The variation of Epa with the electrolyte pH obtained
always in a solution of 5 mM glivec, shows that the peak 1a
and 2a potentials are displaced to less positive values by
increasing the pH of the supporting electrolyte, Figure 3A.
Peak 1a potential follows a linear relationship with pH and
the slope of the line is 59 mV per pH unit, Figure 3B, which
shows that the oxidation mechanism of glivec involves the
same number of electrons and protons. Nevertheless, in all
electrolytes, the width at half height of the glivec oxidation
peak 1a wasW1/2¼ 55 mV, which suggests that the oxidation
of glivec occurs with the transfer of 2 electrons, hence also 2
protons.
Fig. 3. A) 3D plot of DPVobtained in 5 mM glivec as function of
pH. B) Plot of (*) Epa and (~) Ipa of peak 1a and of (*) Epa and (~)
Ipa of peak 2a vs. pH.
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On the other hand, Figure 3A also shows that peak 2a
occurs only in electrolytes with pH between 2.6 and 9.2. The
E2pa dependence on pH is linear, the slope of 60 mV per pH
unit, Figure 3B, showing that the glivec oxidation peak 2a
also involves the same number of electrons and protons.
Taking into consideration the width at half height of the
oxidation peak 2a, W1/2¼ 85 mV, it was concluded that the
oxidation occurs with the transfer of 1 electron, hence also 1
proton.
Figure 3B also shows the variation of peaks 1a and 2a
oxidation currents with the pHof the supporting electrolyte.
For peak 1a two current maxima were observed: in pH 4.5
0.1 M acetate buffer and in pH 7 0.1 M phosphate buffer.
Peak 2a shows higher oxidation currents in pH 4.5 0.1 M
acetate buffer. For this reason, this electrolyte was used for
further investigations.
Successive DP voltammograms were also recorded in a
solution of 5 mM glivec in pH 4.5 0.1 M acetate buffer,
Figure 4A. The oxidation of glivec, peak 1a, occurs at
E1pa¼þ0.90 V followed by peak 2a at E2pa¼þ1.22 V. In a
second DP scan, a new peak 3a occurs at E3pa¼þ0.32 Vand
the oxidation current increases with the number of scans.
This peak corresponds to oxidation of glivec oxidation
product, Pglivec, which is strongly adsorbed at the GCE
surface. At the same time, the oxidation peaks 1a and 2a
decrease gradually with the number of scans due to the
decrease of the available electrode surface because of
adsorption of Pglivec.
The adsorption of Pglivec at theGCE surfacewas confirmed
when after several DP scans recorded in the solution of
glivec the electrodewaswashedwith a jet of deionizedwater
and then transferred to the supporting electrolyte. The DP
voltammogram obtained in these conditions, Figure 4B,
shows both the oxidation of Pglivec, peak 3a and peak 1a due to
the oxidation of glivec. Thatmeans glivec also adsorbs at the
GCE surface. However, on a second DP scan, peak 1a
disappeared due to a complete oxidation of adsorbed glivec
molecules. On the other hand, peak 3a could still be
identified with a higher current. In fact, consecutively
recorded DP voltammograms in buffer showed a slow
decrease of the peak 3a oxidation current only after 15
consecutive scans in buffer.
3.1.3. Square-Wave Voltammetry
The advantages of square-wave voltammetry (SWV) are
greater speed of analysis, lower consumption of the electro-
active species in relation with DPV, and reduced problems
with poisoning of the electrode surface [28]. Another
greater advantage of square-wave methods is the possibility
to see during only one scan if the electron transfer reaction is
reversible or not. Since the current is sampled in both
positive and negative-going pulses, peaks corresponding to
the oxidation and reduction of the electroactive species at
the electrode surface can be obtained in the same experi-
ment.Also, SWVexperiments show a higher sensitivity than
DPV since much faster scan rates can be used (100 mV s1
for SWV compared to 5 mV s1 for DPV).
SWV showed similar features to CV, i.e., oxidation peaks
1 ’a, 1 ’’a and a strong adsorption of electrode reaction products
on the second scan. The first SW scan obtained in a solution
of 5 mM glivec in pH 4.5 0.1 M acetate buffer, shows the
narrow glivec oxidation peak 1 ’a followed by a broader
peak 1 ’’a (Fig. 5A).
On a second SW scan, peak 3a occurs at E2pa¼þ0.32 V,
Figure 5B. The reversibility of peak 3a is confirmed by
plotting the forward and backward components of the total
current where the oxidation and the reduction currents are
equal. Moreover, the identical value of the potential of
peak 2a on the forward and backward current components is
an indication of the adsorption of glivec oxidation products
on the GCE surface [28].
3.2. Reduction
3.2.1. Cyclic Voltammetry
The reduction of glivec at a GCE was studied in pH 4.5
0.1 M acetate buffer. The CV obtained in a 50 mM glivec
Fig. 4. DPV obtained in pH 4.3 0.1 M acetate buffer: A) (—) 1st,
(– – ––) 2nd, and ( · · · · · · ) 3rd scan in 5 mM glivec; B) (—) 1st, ( · · · · · · )
2nd, and (– – ––) 15th scan after transferring to buffer. For more
details see Section 3.1.2.
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solution at a scan rate v¼ 500 mV s1, Figure 6, shows one
cathodic peak 4c that occurs at Epa¼0.89 V. On scanning
in the positive direction, no oxidation peak is observed,
showing that the reduction of glivec is an irreversible
process and the reduction products are not electroactive. A
small decrease of the reduction current occurs with the
number of successive scans and is due to the adsorption of
glivec reduction products on the GCE surface.
CVs were obtained for different scan rates in a solution of
50 mM glivec. It was observed that, on increasing v, peak 4c
potential is slightly displaced to more negative values. The
dependence is linear with the decimal logarithm of the scan
rate with a slope of26 mV per decade. Knowing that for a
diffusion-controlled irreversible system j dEp/d logv j¼
29.6/(acn’) where ac is the charge transfer coefficient and
nM the number of electrons in the rate-determining step [29],
it can be calculated that acn’¼ 1.1.
Also, increasing the scan rate, the current of peak 4c
increases linearly with the square root of v (not shown),
consistent with the diffusion-limited reduction of a solution
species. The peak current in amperes for a diffusion-
controlled irreversible system is given by
Ipc(A)¼2.99 105 n (acn’)1/2 A [O]1 DO1/2 v1/2
where n is the number of electrons transferred during the
oxidationof glivec (n¼ 2 as shownbelow, Section 3.2.2),A is
the electrode area in cm2, DO is the diffusion coefficient in
cm2 s1, [O]1 is the concentration inmol cm
3 and v is inV s1
[29]. By plotting Ipc vs. v
1/2, the value of DO is obtained. For
the measured slope of 2.59 106 A/(V s1)1/2 the diffu-
sion coefficient of glivec in pH 4.5 0.1 M phosphate buffer is
DO¼ 7.2 106 cm2 s1. For this calculation, the GCE
electroactive area was determined from a plot Ipc vs. v
1/2
using a solution of 0.5 mM hexacyanoferrate and the value
of the diffusion coefficient of hexacyanoferrate in phos-
phate buffer ofDO¼ 7.35 106 cm2 s1 [30]. In this way, the
electroactive area 0.031 cm2 was determined.
3.2.2. Differential Pulse Voltammetry
The electrochemical reduction of glivec was studied over a
wide pH range between 2 and 13 using DPV. The DP
voltammograms, Figure 7A, were all recorded in solutions
of 50 mM glivec in different electrolytes with 0.1 M ionic
strength. Only one peak 4c occurs in all supporting electro-
lytes.
The peak 4c potential is displaced tomore negative values
with increasing pH.The dependence is linear over thewhole
pH range, Figure 7B, and follows the relationshipEpc (V)¼
0.51 – 0.061 pH. The slope of 61 mV per pH unit, shows
that the same number of electrons and protons is involved in
the reduction mechanism of glivec. However, the width at
half-height of peak 4c was always W1/2¼ 60 mV, which
suggests that the reduction of glivec occurs with 2 electron
transfer, hence also 2 protons.
Fig. 5. SWV obtained in a solution of 5 mM glivec in pH¼ 4.3
0.1 M acetate buffer: A) 1st and B) 2nd scan; f¼ 50 Hz, DE¼ 1 mV
thus veffective¼ 50 mV s1.
Fig. 6. CV obtained in N2 saturated solution of 50 mM glivec
pH 4.3 0.1 M acetate buffer; (—) 1st, ( · · · · · · ) 2nd, and (– – ––) 3rd
scan at v¼ 500 mV s1.
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The plot of the variation of peak 4c current versus pH,
Figure 7B, shows comparable cathodic currents for pH
between 4 and 10.
The results presented increase the overall understanding
of the redoxproperties of glivec.Adetailed characterization
of glivecMs redox behavior has been carried out allowing the
determination of several important parameters, such as the
number of electrons and protons involved in the redox
processes of glivec and the diffusion coefficient. Never-
theless, glivecMs redox mechanism can only be fully charac-
terized when the products of electrode reaction are identi-
fied. This will only be possible using other analytical
methodologies in order to identify the groups which under-
go oxidation and reduction, establish the sequence of
electron and proton transfer and also to characterize the
products of electrode reaction.
4. Conclusions
The study of the redox behavior of different organic
compounds using electrochemical techniques can provide
valuable insights into the biological redox reactions of these
molecules. Different voltammetric methods have been used
to study the redox behavior of the antileukemia drug glivec,
which undergoes oxidation and reduction at a glassy carbon
electrode.
The oxidation of glivec is an irreversible process that
occurs in cascade, two consecutive charge transfer reactions
being observed. Glivec oxidation involves the formation of
an oxidation product, which adsorbs strongly on the GCE
surface and undergoes reversible oxidation. The formation
of a compact monolayer of glivec oxidation product at the
GCE surface, led to the inhibition of glivec oxidation in
subsequent cyclic voltammetric scans. The oxidation of
glivec is also pHdependent, and occurswith the transfer of 2
electrons and 2 protons.
The reduction of glivec is a simple, pH dependent
irreversible process that proceeds with the transfer of 2
electrons and 2 protons. The diffusion coefficient of glivec
was calculated tobeDO¼ 7.35 106 cm2 s1 in pH 4.5 0.1 M
acetate buffer.
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